Kearns & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,770
| Closed | -$204K | – | 43 |
|
|
2024
Q1 | $204K | Buy |
+3,770
| New | +$204K | 0.16% | 42 |
|
|
2023
Q4 | – | Sell |
-3,770
| Closed | -$219K | – | 43 |
|
|
2023
Q3 | $219K | Hold |
3,770
| – | – | 0.21% | 39 |
|
|
2023
Q2 | $241K | Hold |
3,770
| – | – | 0.22% | 35 |
|
|
2023
Q1 | $261K | Hold |
3,770
| – | – | 0.26% | 32 |
|
|
2022
Q4 | $271K | Buy |
+3,770
| New | +$271K | 0.29% | 30 |
|